BillionToOne, Inc. (BLLN) Stock

BillionToOne, Inc. (BLLN) is a Healthcare stock trading at $104.72 (as of 2026-06-18), with a market capitalization of $5.00B and a trailing P/E of 114.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

BillionToOne, Inc. is a precision diagnostics company that performs molecular tests to quantify biological signals for disease detection and monitoring. Its offerings include UNITY Complete non-invasive prenatal screening, Northstar Select liquid biopsy mutation profiling, and Northstar Response for longitudinal cancer burden assessment, serving clinical and research customers.

Valuation — source: SEC EDGAR (first-party)
Price$104.72
Market Cap$5.00B
P/E Ratio114.2
EV / EBITDA112.1
Price / Book10.42
Price / Sales14.86
DCF Value (model)$33.27
DCF Upside vs Price-68.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$305.11M
Net Margin2.4%
Return on Equity5.8%
Debt / Equity0.18
Current Ratio10.92
Revenue Growth (YoY)83.8%
EPS Growth (YoY)-200.0%
FCF Growth (YoY)3842.1%
Financial Health — source: SEC EDGAR
Altman Z-Score9.67 (safe)
Valuation vs Sector & Industry
Stock P/E114.2
Sector P/E (Healthcare)21.0
Industry P/E (Healthcare Services)23.0
vs Sector445.0%
vs Industry395.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderADAMS STREET PARTNERS LLC ($135.10M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryHealthcare Services
CEOOguzhan Atay
Employees620
CountryUS
IPO Date2025-11-06

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • GRAIL, Inc. (GRAL)
  • QuidelOrtho Corporation (QDEL)
  • Celldex Therapeutics, Inc. (CLDX)
  • Fortrea Holdings Inc. (FTRE)
  • Anbio Biotechnology Class A Ordinary Shares (NNNN)
  • Neogen Corporation (NEOG)
  • Castle Biosciences, Inc. (CSTL)
  • CareDx, Inc (CDNA)
BLLN earnings history · BLLN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.